SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Volumn 5, Issue 2, 2016, Pages

Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancer

(2) Pal, Sumanta K a Kortylewski, Marcin a

a CITY OF HOPE NATIONAL MEDICAL CENTER (United States)

Author keywords

Arginase; immunotherapy; MDSC; myeloid derived suppressor cells; prostate cancer; STAT3; TLR9

Indexed keywords

EID: 84959432867 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.1080/2162402X.2015.1078060 Document Type: Article

Times cited : (7)

References (10)

1
- 84858785703
- Coordinated regulation of myeloid cells by tumours
- 22437938
- D.I.Gabrilovich, S.Ostrand-Rosenberg, V.Bronte. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
- (2012) Nat Rev Immunol , vol.12 , pp. 253-268
- Gabrilovich, D.I.¹ Ostrand-Rosenberg, S.² Bronte, V.³

2
- 76149145359
- Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer
- S.Vuk-Pavlovic, P.A.Bulur, Y.Lin, R.Qin, C.L.Szumlanski, X.Zhao, A.B.Dietz. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate 2010 Mar 1; 70(4):443-55; PMID:19902470; http://dx.doi.org/10.1002/pros.21078
- (2010) Prostate , vol.70 , Issue.4 , pp. 443-455
- Vuk-Pavlovic, S.¹ Bulur, P.A.² Lin, Y.³ Qin, R.⁴ Szumlanski, C.L.⁵ Zhao, X.⁶ Dietz, A.B.⁷

3
- 84942897448
- TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
- 25967142
- D.M.Hossain, S.K.Pal, D.F.D.Moreira, P.Duttagupta, Q.Zhang, H.Won, J.Jones, M.D'Apuzzo, S.Forman, M.Kortylewski. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients. Clin Cancer Res 2015; 21(16):3771-82; PMID:25967142; http://dx.doi.org/10.1158/1078-0432.CCR-14-3145
- (2015) Clin Cancer Res , vol.21 , Issue.16 , pp. 3771-3782
- Hossain, D.M.¹ Pal, S.K.² Moreira, D.F.D.³ Duttagupta, P.⁴ Zhang, Q.⁵ Won, H.⁶ Jones, J.⁷ D'Apuzzo, M.⁸ Forman, S.⁹ Kortylewski, M.¹⁰

4
- 79953300942
- CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice
- 21233400
- C.Zoglmeier, H.Bauer, D.Norenberg, G.Wedekind, P.Bittner, N.Sandholzer, M.Rapp, D.Anz, S.Endres, C.Bourquin. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res 2011; 17:1765-75; PMID:21233400; http://dx.doi.org/10.1158/1078-0432.CCR-10-2672
- (2011) Clin Cancer Res , vol.17 , pp. 1765-1775
- Zoglmeier, C.¹ Bauer, H.² Norenberg, D.³ Wedekind, G.⁴ Bittner, P.⁵ Sandholzer, N.⁶ Rapp, M.⁷ Anz, D.⁸ Endres, S.⁹ Bourquin, C.¹⁰

5
- 84859489110
- CpG still rocks! Update on an accidental drug
- 22352814
- A.M.Krieg. CpG still rocks! Update on an accidental drug. Nucleic acid therapeutics 2012; 22:77-89; PMID:22352814; http://dx.doi.org/10.1089/nat.2012.0340
- (2012) Nucleic acid therapeutics , vol.22 , pp. 77-89
- Krieg, A.M.¹

6
- 65549111372
- Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy
- 19258507
- M.Kortylewski, M.Kujawski, A.Herrmann, C.Yang, L.Wang, Y.Liu, R.Salcedo, H.Yu. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res 2009; 69:2497-505; PMID:19258507; http://dx.doi.org/10.1158/0008-5472.CAN-08-3031
- (2009) Cancer Res , vol.69 , pp. 2497-2505
- Kortylewski, M.¹ Kujawski, M.² Herrmann, A.³ Yang, C.⁴ Wang, L.⁵ Liu, Y.⁶ Salcedo, R.⁷ Yu, H.⁸

7
- 84891277691
- TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
- 24154870
- C.Gao, A.Kozlowska, S.Nechaev, H.Li, Q.Zhang, D.M.Hossain, C.M.Kowolik, P.Chu, P.Swiderski, D.J.Diamond et al. TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy. Cancer Res 2013; 73:7211-21; PMID:24154870; http://dx.doi.org/10.1158/0008-5472.CAN-13-1314
- (2013) Cancer Res , vol.73 , pp. 7211-7221
- Gao, C.¹ Kozlowska, A.² Nechaev, S.³ Li, H.⁴ Zhang, Q.⁵ Hossain, D.M.⁶ Kowolik, C.M.⁷ Chu, P.⁸ Swiderski, P.⁹ Diamond, D.J.¹⁰

8
- 70349971417
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
- 19749770
- M.Kortylewski, P.Swiderski, A.Herrmann, L.Wang, C.Kowolik, M.Kujawski, H.Lee, A.Scuto, Y.Liu, C.Yang et al. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat Biotechnol 2009; 27:925-32; PMID:19749770; http://dx.doi.org/10.1038/nbt.1564
- (2009) Nat Biotechnol , vol.27 , pp. 925-932
- Kortylewski, M.¹ Swiderski, P.² Herrmann, A.³ Wang, L.⁴ Kowolik, C.⁵ Kujawski, M.⁶ Lee, H.⁷ Scuto, A.⁸ Liu, Y.⁹ Yang, C.¹⁰

9
- 84874449237
- TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
- 23287859
- Q.Zhang, D.M.Hossain, S.Nechaev, A.Kozlowska, W.Zhang, Y.Liu, C.M.Kowolik, P.Swiderski, J.J.Rossi, S.Forman et al. TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo. Blood 2013; 121:1304-15; PMID:23287859; http://dx.doi.org/10.1182/blood-2012-07-442590
- (2013) Blood , vol.121 , pp. 1304-1315
- Zhang, Q.¹ Hossain, D.M.² Nechaev, S.³ Kozlowska, A.⁴ Zhang, W.⁵ Liu, Y.⁶ Kowolik, C.M.⁷ Swiderski, P.⁸ Rossi, J.J.⁹ Forman, S.¹⁰

10
- 84938254969
- TLR9 signaling through NF-kappaB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
- 26046794
- D.Moreira, Q.Zhang, D.M.Hossain, S.Nechaev, H.Li, C.M.Kowolik, M.D'Apuzzo, S.Forman, J.Jones, S.K.Pal et al. TLR9 signaling through NF-kappaB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells. Oncotarget 2015; 6(19):17302-13; PMID:26046794; http://dx.doi.org/10.18632/oncotarget.4029
- (2015) Oncotarget , vol.6 , Issue.19 , pp. 17302-17313
- Moreira, D.¹ Zhang, Q.² Hossain, D.M.³ Nechaev, S.⁴ Li, H.⁵ Kowolik, C.M.⁶ D'Apuzzo, M.⁷ Forman, S.⁸ Jones, J.⁹ Pal, S.K.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.